main webpage
W Topic
Hematopoietic Stem Cell Transplantation
Clinics and Research in Hepatology and Gastroenterology • Vol 45 • No 4
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients
2021
Article

Hematopoietic Stem Cell Transplantation

Medical procedure to replace blood or immune stem cells

Hematopoietic stem-cell transplantation ( HSCT ) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood in order to replicate inside of a patient and to produce additional normal blood cells. It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).

It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation.

Exploring foci of:
Clinics and Research in Hepatology and Gastroenterology • Vol 45 • No 4
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients
2021
Click Hematopoietic Stem Cell Transplantation Vs:
Medicine
Malignancy
Liver Transplantation
Internal Medicine
Primary Sclerosing Cholangitis
Liver Disease
Cancer
Oncology
Disease
Click Hematopoietic Stem Cell Transplantation Vs:
Environmental Health